Condition: Rectal Cancer Patients · Sponsor: Henry Smith
A Phase I clinical trial that will investigate the safety and tolerability of combining the modified vaccinia virus BT-001 with systemic pembrolizumab in patients with localised pMMR rectal cancer
This description comes directly from the study's public registry record.
Henry G Smith, PhD · +4521701936 · henry.george.smith@regionh.dk
Always discuss trial participation with your own doctor first.
| Copenhagen University Hospital - Bispebjerg and Frederiksberg | Copenhagen, Captial Region, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07687875